# A Phase III Efficacy Study of the Symptomatic Treatment of Seasonal Allergic Rhinitis With Bilastine

> **NCT01108783** · PHASE3 · COMPLETED · sponsor: **Faes Farma, S.A.** · enrollment: 720 (actual)

## Conditions studied

- Seasonal Allergic Rhinitis

## Interventions

- **DRUG:** Bilastine
- **DRUG:** Desloratadine
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT01108783
- **Lead sponsor:** Faes Farma, S.A.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2003-04
- **Primary completion:** 2003-08
- **Final completion:** 2004-02
- **Target enrollment:** 720 (ACTUAL)
- **Last updated:** 2012-04-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01108783

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01108783, "A Phase III Efficacy Study of the Symptomatic Treatment of Seasonal Allergic Rhinitis With Bilastine". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT01108783. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*